National Institutes of Health
9000 Rockville Pike
Bethesda, MD 20892
Often late stage clinical trials are terminated due to cardiotoxicity. There is great need to develop proper screens that are predictive of human clinical response to medications. This course will cover numerous applications using cardiomyocytes.